Physician profile
Jerome R Switch
NPI 1467464032
$3,508.94
in general payments reported to CMS, 2019-2025
30 companies · $728 in 2025
The $728 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $279 · 2020: $297 · 2021: $509 · 2022: $746 · 2023: $599 · 2024: $351 · 2025: $728.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,606 · Entertainment: $72.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,606.06 |
| Entertainment | $72.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,357.47 | 2019-2025 | Clareon, Argos, Hydrus Microstent |
| Bausch & Lomb Americas INC. | $236.82 | 2022-2025 | Xiidra, Miebo, Envista Mx60 Iol |
| Apellis Pharmaceuticals, INC. | $185.48 | 2023-2025 | Syfovre |
| Sun Pharmaceutical Industries INC. | $135.10 | 2020-2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $113.71 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $110.14 | 2024-2025 | Xdemvy |
| Oyster Point Pharma, INC. | $100.65 | 2022-2023 | Tyrvaya |
| Sight Sciences, INC. | $97.79 | 2019-2024 | Omni Surgical System |
| Omeros Corporation | $96.58 | 2020-2021 | |
| Aerie Pharmaceuticals, INC. | $93.63 | 2019-2021 | |
| Rayner Intraocular Lenses Limited | $92.48 | 2022-2023 | Rayone Spheric, Rayone Aspheric, Rayone Emv |
| New World Medical,INC. | $90.23 | 2021-2025 | Clearpath, Streamline, Ahmed Glaucoma Valve |
| Rxsight INC | $83.72 | 2025 | Rxsight Contact Lens, Rxsight Injector Cartridge, Light Adjustable Lens (Lal) |
| Novartis Pharmaceuticals Corporation | $80.62 | 2020-2022 | |
| Lombart Brothers, INC. | $80.13 | 2019-2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $76.29 | 2020-2022 | |
| Optos, INC. | $72.05 | 2023-2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Eyevance Pharmaceuticals LLC | $59.58 | 2021-2022 | |
| Biotissue Holdings INC. | $51.11 | 2021-2023 | |
| Abbvie INC. | $49.08 | 2022-2023 | Durysta |
| Thea Pharma INC. | $42.52 | 2025 | Iyuzeh |
| Mallinckrodt Hospital Products INC. | $38.60 | 2021 | |
| Beaver-Visitec International, INC. | $30.18 | 2020 | |
| Dompe US, INC. | $22.46 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $22.15 | 2019 | |
| Amgen INC. | $20.14 | 2025 | Tepezza |
| Astellas Pharma US INC | $19.68 | 2023 | Izervay |
| Akorn Operating Company LLC | $19.60 | 2021 | |
| Shire North American Group INC | $17.25 | 2019 | |
| Horizon Therapeutics Plc | $13.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerome Switch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.